67362 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 

Controlled substance Drug code Schedule 

Para-Methoxymethamphetamine (PMMA), 1-(4- methoxyphenyl)-N-methylpropan-2-amine ................................. 1245 I 

Aminorex ................................................................................................................................................................. 1585 I 

Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6Hthieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine ......................... 2780 I 

Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) .................... 2785 I 

Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ........................... 2786 I

Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ................... 2788 I 

Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one ........ 2789 I 

Piritramide ............................................................................................................................................................... 9642 I 

Lisdexamfetamine ................................................................................................................................................... 1205 II 

Oliceridine (N-[(3-methoxythiophen-2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-oxaspiro[4.5] decan-9-yl] ethyl 

{time})amine fumarate).

9245 II 

Levo-alphacetylmethadol ......................................................................................................................................... 9648 II 

Remifentanil ............................................................................................................................................................. 9739 II 

Tapentadol ............................................................................................................................................................... 9780 II 

The company plans to import the 

listed controlled substances for 

distribution for analytical testing 

purposes. No other activities for these 

drug codes are authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–21398 Filed 9–28–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1272] 

Bulk Manufacturer of Controlled 

Substances Application: Restek 

Corporation 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Restek Corporation has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before November 28, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before November 28, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on June 21, 2023, Restek 

Corporation, 110 Benner Circle, 

Bellefonte, Pennsylvania 16823–8433, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

Gamma Hydroxybutyric Acid ................................................................................................................................... 2010 I 

Methaqualone .......................................................................................................................................................... 2565 I 

JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................... 7118 I 

JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................. 7200 I 

CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ........................................................ 7297 I 

CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .................................. 7298 I 

Lysergic acid diethylamide ...................................................................................................................................... 7315 I 

Marihuana ................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols ............................................................................................................................................ 7370 I 

4-Methyl-2,5-dimethoxyamphetamine ..................................................................................................................... 7395 I 

3,4-Methylenedioxyamphetamine ............................................................................................................................ 7400 I 

3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine .................................................................................................................... 7405 I 

Bufotenine ............................................................................................................................................................... 7433 I 

Psilocybin ................................................................................................................................................................ 7437 I 

Psilocyn ................................................................................................................................................................... 7438 I 

Cyprenorphine ......................................................................................................................................................... 9054 I 

Dihydromorphine ..................................................................................................................................................... 9145 I 

Heroin ...................................................................................................................................................................... 9200 I 

Normorphine ............................................................................................................................................................ 9313 I 

Beta-hydroxyfentanyl ............................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl ................................................................................................................................ 9831 I 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 67363 

The company plans to bulk 

manufacture the listed controlled 

substances for DEA exempted certified 

reference materials. In-house synthesis 

gives access to compounds that are 

difficult to source. No other activities 

for these drug codes are authorized for 

this registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–21401 Filed 9–28–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1277] 

Importer of Controlled Substances 

Application: Restek Corporation 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Restek Corporation has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 30, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 30, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on August 24, 2023, Restek 

Corporation, 110 Benner Circle, 

Bellefonte, Pennsylvania 16823–8433, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug code Schedule 

Amineptine ....................................................................................................................................................................... 1219 I 

Mesocarb ......................................................................................................................................................................... 1227 I 

3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. 1233 I 

Cathinone ........................................................................................................................................................................ 1235 I 

Methcathinone ................................................................................................................................................................. 1237 I 

4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. 1238 I 

Para-Methoxymethamphetamine (PMMA), 1-(4–1245 I N methoxyphenyl)-N-methylpropan-2-amine .......................... 1245 I 

Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone ..................................................................................................................... 1248 I 

4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... 1249 I 

Naphyrone ....................................................................................................................................................................... 1258 I 

N-Ethylamphetamine ....................................................................................................................................................... 1475 I 

Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- 1478 I N amine) ...................................................................... 1478 I 

N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I 

Fenethylline ..................................................................................................................................................................... 1503 I 

Aminorex .......................................................................................................................................................................... 1585 I 

4-Methylaminorex (cis isomer) ........................................................................................................................................ 1590 I 

4,4′-Dimethylaminorex ..................................................................................................................................................... 1595 I 

Methylphenidate .............................................................................................................................................................. 1724 I 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Methaqualone .................................................................................................................................................................. 2565 I 

Mecloqualone .................................................................................................................................................................. 2572 I 

JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................. 6250 I 

SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................ 7008 I 

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7010 I 

5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................ 7011 I 

AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 7012 I 

FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ............................................... 7014 I 

JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... 7019 I 

MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...................... 7020 I 

FUB–AMB, MMB- FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- 

methylbutanoate).

7021 I 

AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 7023 I 

THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ................................................................. 7024 I 

5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ........................ 7025 I 

AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ............... 7031 I 

MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........ 7032 I 

5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .............................................. 7033 I 

5F–ADB, 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...... 7034 I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7035 I

5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......................... 7036 I 

5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) .............................. 7041 I 


lotter on DSK11XQN23PROD with NOTICES1